Neurocrine Biosciences, Inc. · NASDAQ:NBIX
Lippoldt Darin received 4,483 Neurocrine Biosciences, Inc. shares as an award (Form 4)
Traded Sep 11, 2026 · Filed Sep 15, 2026
On Sep 11, 2026, Lippoldt Darin (Chief Legal Officer) received 4,483 Neurocrine Biosciences, Inc. shares as an award, leaving 56,793 shares. Filed Sep 15, 2026 (Form 4).
- Awarded
- 4,483 shares
- Holding after
- 56,793 shares
- Trading plan
- No
- Role
- Chief Legal Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Sep 11, 2026 | Common Stock | Award | 4,483 | 59,212 | Direct | |
| Sep 11, 2026 | Common Stock | Shares withheld for tax | 2,419 | US$156.22 | 56,793 | Direct |
Source
Related
- Neurocrine Biosciences, Inc.
- Lippoldt Darin
- Neurocrine Biosciences, Inc. shareholders
- Form 4 · Lippoldt Darin · Jul 13, 2026
- Form 4 · Lippoldt Darin · Jun 30, 2026
- Schedule 13G/A · JPMorgan Chase & Co · Oct 15, 2026
- Form 4 · Boyer David W. · Sep 15, 2026
- Form 4 · Abernethy Matt · Sep 15, 2026
- Form 4 · Gano Kyle · Sep 15, 2026
- Form 4 · Onyia Jude · Sep 15, 2026